Abstract
Gloydius venom is a rich natural source of proteins possessing platelet aggregation inhibition activity. These proteins or their recombinant analogs are universal instruments for the investigation of proteins and receptors interaction in hemostatic system. At the same time previously studied and potentially new pharmacological properties of platelet aggregation inhibitors from snake venoms create a background for the development of the manufacturing technologies. This study presents a part of technological development of several target proteins parallel obtaining from G. blomhoffii brevicaudus snake venom, in particular development of manufacturing steps for platelet aggregation inhibitor.The target protein was purified using three different chromatographic approaches. It was shown that it is a single chain protein with molecular weight 12001.55 Da, isoelectrical point 8.03, which inhibited platelet aggregation in the rabbit platelet rich plasma with ID 50 = 3.26×10 -6 g or 542×10 -9 М and revealing no enzyme activity. Keywords: snake venom, G. blomhoffii brevicaudus , platelet aggregation inhibitor, protein chromatography.
Highlights
До теперішнього часу описано більше 20 інгібіторів агрегації тромбоцитів із отрути змій роду Gloydius* (Agkistrodon)
Що він є одноланцюговий протеїн із молекулярною масою
This study presents a part of technological development of several target proteins parallel obtaining from G. blomhoffii brevicaudus snake venom
Summary
Трипептид AAP АДФ-аза Фосфоліпаза А2 фібриногенолітик SV-PP-1 (1235 Дa) SV-PP-2 (23339 Дa). Метою нашого дослідження було розробити спосіб очищення та дати характеристику інгібітору агрегації тромбоцитів з отрути G. blomhoffii brevicaudus, вміст якого було показано раніше [2]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.